Skip to content

Pain in Subjects with High Capacity Cognitive Abilities

Pain in Subjects with High Capacity Cognitive Abilities: a Cross Sectional Study

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06695351
Enrollment
150
Registered
2024-11-19
Start date
2024-12-31
Completion date
2025-06-30
Last updated
2024-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Cognitive Abilities, Pain, Prevalence

Keywords

high cognitive abilities, Pain, Prevalence, Kinesiophobia, Catastrophising, giftedness

Brief summary

In many books and website focused in high cognitive abilities talks about pain in these subjects. However, when the investigators look for in sites like pubmed there are no literature about this topic. With this study the investigators will try to know better pain experience in this population and chronic pain prevalence

Detailed description

It's said that people with high cognitive abilities suffered pain. However, there are no scientific literature. With this study the investigators would like to know better pain experience in this population. There are two target groups include inside this population that we consider to study: Children population and adults population. The aim of this study is to know the prevalence of chronic pain in this population and to analize the pain experience of this population and the related psychosocial variables that can modify it, like catastrophicing, kinesiophobia, anxiety, quality of life and level of physical activity, The investigators will use a questionnaire that includes different questionnaires like TSK-11SV, PCS, STAI, SF-36 and IPAQ and many question to evaluate the demographic factor of the sample and the prevalence The investigators will do an statistical analysis to observe the relationship and the predictors factors

Interventions

None listed

Sponsors

Universidad Europea de Madrid
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* People with a diagnosis of high cognitive abilities

Exclusion criteria

* People with incapacity to answer the questionnaire * People that's not have a good level of Spanish language

Design outcomes

Primary

MeasureTime frameDescription
Perceived quality of life1 dayPerceived quality of life was measured with the 36Item Short Form Health Survey (SF-36) scale validated in Spanish. This self-administered scale consists of 36 items in eight domains: physical functioning, limitations due to physical problems, physical pain, social role or function, mental health, limitations due to emotional problems, vitality and general perception of health.

Secondary

MeasureTime frameDescription
Kinesiophobia1 dayThe Tampa Scale of Kinesiophobia (TSK-11) was used to assess patients' fear of moving or engaging in physical activity. We used the Spanish version of this self-administered instrument, which consists of 11 items rated on a 4-point Likert scale. The total score ranges from 11 to 44, with higher values corresponding to a greater fear of being injured again by the movement. Scores of more than 27 points are considered high. The minimum detectable change of this instrument is 5.6
Catastrophising1 dayCatastrophism was assessed with the Pain Catastrophizing Scale. This scale is composed of 13 items rated on a scale from 0 to 4 points (a lower score indicates lower catastrophism). The questionnaire used is validated in Spanish
Anxiety1 dayAnxiety was evaluated with the validated Spanish version of the State-Trait Anxiety inventory (STAI) questionnaire. This measuring instrument has two self-assessment scales to measure two independent anxiety concepts: state and trait. Both scales have 20 items each, which are scored on a Likert scale having four possible replies (from 0 to 3). This questionnaire presents a good internal consistency in the Spanish version in anxiety/state (Cronbach's α = .90 - .93) and in anxiety/trait (Cronbach's α = .84 - .87)
Physical activity1 dayThe instrument used to determine participants' PA level was the IPAQ short form. Total weekly amount of PA was calculated according to the method for computation of metabolic equivalent of task (MET)minutes/week, previously established in the IPAQ instructions for analysis and data processing of the questionnaire. Then, PA level was classified as: low (\<600 METmin/week), moderate ( 600 METmin/week) and high ( 3000 METmin/week), following the same guidelines. This questionnaire has acceptable validity ( = 0.30, 95% CI: 0.23-0.36) and reliability (Spearman's =0.81, 95%CI:0.79-0.82) \[30\]. It has also been validated in Spain (r = 0.277; p \< 0.05; 75% of specificity and sensibility; k = 0.33).

Other

MeasureTime frameDescription
Pain1 dayThe perceived pain intensity was evaluated using the visual analogue scale. This scale has shown good reliability and validity for the assessment of pain intensity.18 This measuring instrument evaluates the intensity of pain on a 10 cm line (0 being no pain and 10 being the worst pain). Participants were asked to make a mark on the line to represent the average intensity of the usual joint pain they endure in the last 30 days. Similarly, they were asked to mark the maximum degree of pain they report in the last month.

Countries

Spain

Contacts

Primary ContactRoberto Ucero-Lozano, PhD, PhD, PT, MSc, CHT
roberto.ucero@universidadeuropea.es+34 646466265
Backup ContactRubén Cuesta-Barriuso, PhD, PT, MSc
cuesta.ruben@uniovi.es+34607547274

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026